Aprecap Capsule (3’s) is a medication primarily used to prevent nausea and vomiting associated with chemotherapy and surgery. Each capsule contains two strengths of Aprepitant: 125 mg and 80 mg, which work synergistically to block the action of certain natural substances in the body that can trigger nausea and vomiting. Aprepitant is classified as a neurokinin-1 (NK1) receptor antagonist, making it effective in managing acute and delayed nausea and vomiting. This drug is particularly beneficial for patients undergoing cancer treatment, as it helps improve their quality of life by reducing the side effects of chemotherapy. Aprecap Capsule is typically prescribed as part of a comprehensive antiemetic regimen, often in combination with other medications to enhance its effectiveness. Understanding the composition and purpose of Aprecap Capsule is essential for patients and healthcare providers alike, as it plays a crucial role in managing treatment-related side effects.